BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 38205938)

  • 1. HPV16 E6 promoting cervical cancer progression through down-regulation of miR-320a to increase TOP2A expression.
    Zhang J; Yu X; Guo Y; Wang D
    Cancer Med; 2024 Feb; 13(3):e6875. PubMed ID: 38205938
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The HPV16 E6, E7/miR-23b-3p/ICAT signaling axis promotes proliferation, migration, invasion and EMT of cervical cancer cells.
    Hu J; Liao D; Sun Z; Ren W; Zhao L; Fang Y; Hu K; Yu H; Liu S; Zhou L; He T; Zhang Y
    Carcinogenesis; 2023 May; 44(3):221-231. PubMed ID: 36847693
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MicroRNA-27b up-regulated by human papillomavirus 16 E7 promotes proliferation and suppresses apoptosis by targeting polo-like kinase2 in cervical cancer.
    Liu F; Zhang S; Zhao Z; Mao X; Huang J; Wu Z; Zheng L; Wang Q
    Oncotarget; 2016 Apr; 7(15):19666-79. PubMed ID: 26910911
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Human papillomavirus type 16 E7 promotes cell viability and migration in cervical cancer by regulating the miR-23a/HOXC8 axis.
    Chen Y; Sun L; Li L
    J Obstet Gynaecol; 2024 Dec; 44(1):2311658. PubMed ID: 38348790
    [TBL] [Abstract][Full Text] [Related]  

  • 5. miR-3156-3p is downregulated in HPV-positive cervical cancer and performs as a tumor-suppressive miRNA.
    Xia YF; Pei GH; Wang N; Che YC; Yu FS; Yin FF; Liu HX; Luo B; Wang YK
    Virol J; 2017 Feb; 14(1):20. PubMed ID: 28160779
    [TBL] [Abstract][Full Text] [Related]  

  • 6. HPV16 E6 oncoprotein-induced upregulation of lncRNA GABPB1-AS1 facilitates cervical cancer progression by regulating miR-519e-5p/Notch2 axis.
    Ou R; Lv M; Liu X; Lv J; Zhao J; Zhao Y; Li X; Li W; Zhao L; Li J; Ren Y; Xu Y
    FASEB J; 2020 Oct; 34(10):13211-13223. PubMed ID: 32844486
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Human Papillomavirus E6/E7 and Long Noncoding RNA TMPOP2 Mutually Upregulated Gene Expression in Cervical Cancer Cells.
    He H; Liu X; Liu Y; Zhang M; Lai Y; Hao Y; Wang Q; Shi D; Wang N; Luo XG; Ma W; Zhang TC
    J Virol; 2019 Apr; 93(8):. PubMed ID: 30728257
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Human papillomavirus 16 E6/E7 contributes to immune escape and progression of cervical cancer by regulating miR-142-5p/PD-L1 axis.
    Ling J; Sun Q; Tian Q; Shi H; Yang H; Ren J
    Arch Biochem Biophys; 2022 Nov; 731():109449. PubMed ID: 36288761
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Up-regulation of miR-20a by HPV16 E6 exerts growth-promoting effects by targeting PDCD6 in cervical carcinoma cells.
    Liu X
    Biomed Pharmacother; 2018 Jun; 102():996-1002. PubMed ID: 29710555
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Human Papillomavirus 16 Oncoproteins Downregulate the Expression of miR-148a-3p, miR-190a-5p, and miR-199b-5p in Cervical Cancer.
    Han MS; Lee JM; Kim SN; Kim JH; Kim HS
    Biomed Res Int; 2018; 2018():1942867. PubMed ID: 30627542
    [TBL] [Abstract][Full Text] [Related]  

  • 11. HPV16 E6 promotes cervical cancer cell migration and invasion by downregulation of NHERF1.
    Wang Q; Song R; Zhao C; Liu H; Yang Y; Gu S; Feng D; He J
    Int J Cancer; 2019 Apr; 144(7):1619-1632. PubMed ID: 30230542
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The novel circCLK3/miR-320a/FoxM1 axis promotes cervical cancer progression.
    Hong H; Zhu H; Zhao S; Wang K; Zhang N; Tian Y; Li Y; Wang Y; Lv X; Wei T; Liu Y; Fan S; Liu Y; Li Y; Cai A; Jin S; Qin Q; Li H
    Cell Death Dis; 2019 Dec; 10(12):950. PubMed ID: 31831728
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of miR-409-3p in regulation of HPV16/18-E6 mRNA in human cervical high-grade squamous intraepithelial lesions.
    Sommerova L; Anton M; Bouchalova P; Jasickova H; Rak V; Jandakova E; Selingerova I; Bartosik M; Vojtesek B; Hrstka R
    Antiviral Res; 2019 Mar; 163():185-192. PubMed ID: 30711417
    [TBL] [Abstract][Full Text] [Related]  

  • 14. miR-2861 acts as a tumor suppressor via targeting EGFR/AKT2/CCND1 pathway in cervical cancer induced by human papillomavirus virus 16 E6.
    Xu J; Wan X; Chen X; Fang Y; Cheng X; Xie X; Lu W
    Sci Rep; 2016 Jul; 6():28968. PubMed ID: 27364926
    [TBL] [Abstract][Full Text] [Related]  

  • 15. HPV16 oncogenes E6 or/and E7 may influence the methylation status of RASSFIA gene promoter region in cervical cancer cell line HT-3.
    Yin F; Wang N; Wang S; Yu F; Sun X; Yu X; Luo B; Zhao C; Wang Y
    Oncol Rep; 2017 Apr; 37(4):2324-2334. PubMed ID: 28260046
    [TBL] [Abstract][Full Text] [Related]  

  • 16. miR-4454 up-regulated by HPV16 E6/E7 promotes invasion and migration by targeting ABHD2/NUDT21 in cervical cancer.
    Wang H; Hu H; Luo Z; Liu S; Wu W; Zhu M; Wang J; Liu Y; Lu Z
    Biosci Rep; 2020 Sep; 40(9):. PubMed ID: 32816024
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The E6 Oncoprotein of HPV16 AA-c Variant Regulates Cell Migration through the MINCR/miR-28-5p/RAP1B Axis.
    Perez-Bacho EG; Beltrán-Anaya FO; Arechaga-Ocampo E; Hernández-Sotelo D; Garibay-Cerdenares OL; Illades-Aguiar B; Alarcón-Romero LDC; Del Moral-Hernández O
    Viruses; 2022 May; 14(5):. PubMed ID: 35632705
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HPV16 E6 promotes cell proliferation, migration, and invasion of human cervical cancer cells by elevating both EMT and stemness characteristics.
    Lu Y; Chen Y; Zhang Z; Li M; Chen X; Tu K; Li L
    Cell Biol Int; 2022 Apr; 46(4):599-610. PubMed ID: 34957655
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Suppression of miR-22, a tumor suppressor in cervical cancer, by human papillomavirus 16 E6 via a p53/miR-22/HDAC6 pathway.
    Wongjampa W; Ekalaksananan T; Chopjitt P; Chuerduangphui J; Kleebkaow P; Patarapadungkit N; Pientong C
    PLoS One; 2018; 13(10):e0206644. PubMed ID: 30379969
    [TBL] [Abstract][Full Text] [Related]  

  • 20. HPV16 E6 regulates the proliferation, invasion, and apoptosis of cervical cancer cells by downregulating miR-504.
    Zhang L; Lai Y; Sun Y; Xu B; Qiang X; Zhou X; Wang T
    Transl Cancer Res; 2020 Dec; 9(12):7588-7595. PubMed ID: 35117358
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.